Tralesinidase alfa (TA)

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Intracerebroventricular Tralesinidase Alfa in Participants With MPS IIIB (Sanfilippo Syndrome Type B)NCT07579910Spruce BiosciencesPhase 3Not yet recruiting2033-08Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.